Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05362552
Other study ID # AfforestAffect
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 9, 2022
Est. completion date May 20, 2022

Study information

Verified date May 2022
Source Universidad de Granada
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This single-group pretest-posttest clinical trial aims to evaluate the effects of a single-session afforestation activity on affect and vitality levels in a sample of young adults.


Description:

The participants will perform an afforestation activity for a single session of 90 minutes. The therapists will direct the participants' attention to the visual, auditory, olfactory, and tactile features of the surrounding environment.


Recruitment information / eligibility

Status Completed
Enrollment 152
Est. completion date May 20, 2022
Est. primary completion date May 20, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Adults between 18 and 65 years. - Any sex and gender. Exclusion Criteria: - Intake of any psychotropic medication. - Other severe or medically unstable diseases that may interfere with participation. - Severe cognitive impairment (Mini-Mental State Examination score < 17 out of 30 points). - Severe mental disorders in the acute phase or symptomatic phase. - Severe intellectual disability. - Behavioural alterations as this may interfere with their participation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Urban Afforestation Program
An afforestation program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.

Locations

Country Name City State
Spain University of Granada, Faculty of Health Sciences Granada

Sponsors (1)

Lead Sponsor Collaborator
Universidad de Granada

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Affect The Spanish adaptation of the Positive and Negative Affect Schedule will be utilised. Participants rate how they feel at the present moment on a five-point Likert scale, where "not at all or very slightly" is scored as 1 and "a lot" as 5. Scores of two 10-item subscales will be analysed separately in the analysis, labelled either as Positive Affect or Negative Affect. Higher scores in the Positive Affect subscale represent higher levels of positive affect and lower scores in the Negative Affect subscale represent lower levels of negative affect. Change from baseline affect after 90 minutes.
Primary Subjective Vitality The 6-item Spanish adaptation of the Subjective Vitality Scale will be utilised. Participants will transmit their levels of energy and aliveness at the present moment by rating the items on a seven-point Likert scale where 1 stands for "Not true at all" and 7 "Very true". The scores for each item will be summed up for statistical analyses. Higher scores indicate higher levels of energy and aliveness feeling. Change from baseline subjective vitality after 90 minutes.
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1